Start › Rak piersi › Kalifornia › Santa Monica
Badania kliniczne dla Rak piersi w mieście Santa Monica, CA
28 badań dla Rak piersi szuka uczestników w ośrodkach w mieście Santa Monica i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekrutacjaFaza 3
- Beverly Hills Cancer Center, Beverly Hills · 6 mi dalej
A Study of PHST001 in Advanced Solid Tumors
RekrutacjaFaza 1
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi dalej
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
RekrutacjaFaza 2
- Beverly Hills Cancer Center, Beverly Hills · 6 mi dalej
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
RekrutacjaFaza 1
- Research Site, Santa Monica
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1
- Kivu Trial Site, Santa Monica
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekrutacja
- UCLA David Geffen School of Medicine, Santa Monica
A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
RekrutacjaFaza 1
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills · 6 mi dalej
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekrutacjaFaza 3
- Clinical Trial Site, Beverly Hills · 6 mi dalej
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekrutacjaFaza 1
- University of California, Los Angeles (UCLA), Santa Monica
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekrutacjaFaza 3
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
RekrutacjaFaza 2
- UCLA Hematology/Oncology - Parkside, Santa Monica
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekrutacjaFaza 1/2
- Beverly Hills Cancer Center, Beverly Hills · 6 mi dalej
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekrutacjaFaza 3
- Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekrutacjaFaza 3
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills · 6 mi dalej
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekrutacjaFaza 1/2
- Research Site, Santa Monica
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
RekrutacjaFaza 2
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekrutacjaFaza 3
- St. John's Cancer Center, Santa Monica
- UCLA-Department of Medicine Hematology/Oncology-Parkside, Santa Monica
- UCLA-Hetamtology/Oncology_S Monica, Santa Monica
- i 1 więcej
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekrutacjaFaza 3
- Tower Cancer Research Foundation, Beverly Hills · 6 mi dalej
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mi dalej
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi dalej
A Study of Oral MBQ-167 in Participants With Advanced Breast Cancer
RekrutacjaFaza 1
- Precision Next Gen Oncology & Research Center, Beverly Hills · 6 mi dalej
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases
RekrutacjaFaza 2
- CS Cancer at Valley Oncology Medical Group, Tarzana · 11 mi dalej
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekrutacjaFaza 3
- University of California Los Angeles - Hematology / Oncology Parkside, Santa Monica
E-Mindfulness Approaches for Living After Breast Cancer
RekrutacjaFaza 3
- Kaiser Permanente-Woodland Hills, Woodland Hills · 12 mi dalej
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RekrutacjaFaza 2
- University of California Los Angeles Rheumatology, Westwood, Los Angeles · 4 mi dalej
- Precision NextGen Oncology & Research Center, Beverly Hills · 6 mi dalej
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekrutacjaFaza 1/2
- UCLA David Geffen School of Medicine, Division of Hematology/Oncology, Santa Monica
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
RekrutacjaFaza 1
- University of California, Los Angeles, Santa Monica
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekrutacjaFaza 3
- Cedars-Sinai Cancer - Tarzana, Tarzana · 11 mi dalej
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekrutacjaFaza 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
RekrutacjaBadanie obserwacyjne
- John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica
Badania dla Rak piersi w innych miastach
- New York City, NY136 badań
- Houston, TX126 badań
- Boston, MA112 badań
- Nashville, TN81 badań
- Los Angeles, CA73 badań
- Edison, NJ68 badań
- St. Louis, MO64 badań
- Queens, NY64 badań
- Durham, NC64 badań
- Chicago, IL59 badań
- Philadelphia, PA56 badań
- Dallas, TX55 badań
Inne badania w mieście Santa Monica
- Niedrobnokomórkowy rak płuca45 badań
- Rak jelita grubego i odbytnicy23 badań
- Nowotwory (wszystkie typy)22 badań
- Nowotwór przerzutowy19 badań
- Rak płuc15 badań
- Rak jajnika15 badań
- Rak prostaty15 badań
- Rak płaskonabłonkowy głowy i szyi13 badań
- Niewydolność serca11 badań
- Rak endometrium10 badań
- Nowotwór żołądka9 badań
- Rak trzustki9 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.